Pharmadrug Inc. — Investor Relations & Filings
Filings indexed
475
across all filing types
Latest filing
2024-02-12
Regulatory Filings
Country
CA
Canada
Listing
CSE
PHRX
Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2024-02-12 | English | |
| News release - English.pdf | 2024-02-08 | English | |
| News release - English.pdf | 2024-02-01 | English | |
| News release - English.pdf | 2023-12-13 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-11-29 | English | |
| Interim MD&A - English.pdf | 2023-11-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
3 filings
| |||||
| 13718879 | News release - English.pdf | 2024-02-12 | English | ||
| 47677922 | News release - English.pdf | 2024-02-08 | English | ||
| 47677927 | News release - English.pdf | 2024-02-01 | English | ||
|
2023
12 filings
| |||||
| 47677954 | News release - English.pdf | 2023-12-13 | English | ||
| 47677958 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-11-29 | English | ||
| 47677971 | Interim MD&A - English.pdf | 2023-11-29 | English | ||
| 47677978 | Interim financial statements/report – English.pdf | 2023-11-29 | English | ||
| 13706128 | Report of exempt distribution (45-106F1).pdf | 2023-11-24 | English | ||
| 29473732 | News release - English.pdf | 2023-11-15 | English | ||
| 47678148 | Other securityholders documents - English.pdf | 2023-11-13 | English | ||
| 13702847 | News release - English.pdf | 2023-11-09 | English | ||
| 13702808 | News release - English.pdf | 2023-11-09 | English | ||
| 47678153 | Material change report - English.pdf | 2023-11-07 | English | ||
| 47678157 | News release - English.pdf | 2023-11-07 | English | ||
| 47678168 | News release - English.pdf | 2023-11-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Pharmadrug Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46952/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46952 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46952 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46952 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46952}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pharmadrug Inc. (id: 46952)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.